Browse studies

Find your next paid study

1 recruiting study matching your filters

Assessment of Foralumab Safety and Modulation of Microglial Activation Evaluated by PET Imaging in Patients With Early Symptomatic Alzheimer's Disease

This phase 2a study will research the safety and tolerability of Foralumab, a human anti-CD3 antibody. An antibody is a molecule secreted by the immune system.…

DementiaAlzheimers DiseaseMild Cognitive Impairment Due to Alzheimer's Disease

Brigham and Women's HospitalNCT06489548